te Boekhorst Paul Francis Olivier 4
4 · IMMUCELL CORP /DE/ · Filed Nov 12, 2025
Insider Transaction Report
Form 4
te Boekhorst Paul Francis Olivier
DirectorPresident and CEO
Transactions
- Award
Stock Options (right to buy)
2025-11-07$6.10/sh+74,277$453,090→ 150,260 totalExercise: $6.10Exp: 2035-11-07→ Common Stock (74,277 underlying)
Footnotes (1)
- [F1]Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date.